Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety of Polatuzumab-Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) in the Real-World Setting: A Single Institute Retrospective Analysis

Atsushi Otani, Shinichi Ochi, Masami Yamamoto, Shota Yamaguchi, Masahito Uchihara, Shinya Kobayashi, Masanori Matsumoto, Hideo Yagi

Blood (2024) 144 (Supplement 1): 6513.

https://doi.org/10.1182/blood-2024-202897

Published: 2024

Journal Articles

Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation

Blood (2024) 144 (Supplement 1): 2621.

https://doi.org/10.1182/blood-2024-202956

Published: 2024

Journal Articles

Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura

Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Shinya Kobayashi, Hideo Yagi, Masanori Matsumoto

Blood (2023) 142 (Supplement 1): 695.

https://doi.org/10.1182/blood-2023-179143

Published: 2023

Journal Articles

Next-Generation Sequencing of HLA Loci Identifies Predisposing and Protective Factors for Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Japanese Population

Kazuya Sakai, MD, Masataka Kuwana, Hiroto Kojima, Hidenori Tanaka, Masayuki Kubo, Hideo Yagi, Masanori Matsumoto

Blood (2019) 134 (Supplement_1): 1085.

https://doi.org/10.1182/blood-2019-123927

Published: 2019

Journal Articles

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

Kazuya Sakai, MD, Hideo Yagi, MD, Masaki Hayakawa, MD, Tatsuhiko Someya, PhD, Kaori Harada, PhD, Masanori Matsumoto, MD

Blood (2018) 132 (Supplement 1): 2522.

https://doi.org/10.1182/blood-2018-99-113948

Published: 2018

Journal Articles

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Blood (2018) 132 (Supplement 1): 5320.

https://doi.org/10.1182/blood-2018-99-111649

Published: 2018

Journal Articles

Severe Reduction of Free ADAMTS13, Unbound to Von Willebrand Factor, in Plasma Milieu Is a Unique Feature of HELLP Syndrome

Yoko Yoshida, PhD, Ayami Isonishi, Toshiyuki Sado, MD, PhD, Masaki Hayakawa, MD, Hideo Yagi, MD.PhD, Hiroshi Kobayashi, MD, PhD, Yoshihiro Fujimura, MD, PhD, Masanori Matsumoto, MD.PhD

Blood (2016) 128 (22): 134.

https://doi.org/10.1182/blood.V128.22.134.134

Published: 2016

Journal Articles

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Masaki Hayakawa, MD, Seiji Kato, PhD, Taei Matsui, PhD, Kazuya Sakai, MD, Yumi Yoshii, MD, Hideo Yagi, MD.PhD, Yoshihiro Fujimura, MD, PhD, Masanori Matsumoto, MD.PhD

Blood (2016) 128 (22): 3773.

https://doi.org/10.1182/blood.V128.22.3773.3773

Published: 2016

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

Blood (2015) 126 (23): 4341.

https://doi.org/10.1182/blood.V126.23.4341.4341

Published: 2015

Journal Articles

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Rachel K Wee, Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1782.

https://doi.org/10.1182/blood.V126.23.1782.1782

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Hiroyuki Takamatsu, Ryoichi Murata, MD, Jianbiao Zheng, Martin Moorhead, Naoki Takezako, Shigeki Ito, MD PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2015) 126 (23): 1788.

https://doi.org/10.1182/blood.V126.23.1788.1788

Published: 2015

Journal Articles

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Hiroyuki Takamatsu, MD PhD, Ryoichi Murata, MD, Jianbiao Zheng, PhD, Martin Moorhead, PhD, Naoki Takezako, MD PhD, Shigeki Ito, MD, PhD, Toshihiro Miyamoto, MD PhD, Kenji Yokoyama, MD PhD, Kosei Matsue, MD PhD, Tsutomu Sato, MD PhD, Toshiro Kurokawa, MD PhD, Hideo Yagi, MD PhD, Yasushi Terasaki, MD PhD, Kinya Ohata, MD PhD, Takashi Yoshida, MD PhD, Malek Faham, MD PhD, Shinji Nakao, MD PhD

Blood (2014) 124 (21): 2003.

https://doi.org/10.1182/blood.V124.21.2003.2003

Published: 2014

Journal Articles

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Hideo Yagi, MD PhD, Masaki Hayakawa, MD, Naoko Yamaguchi, Keigo Yamashita, MD, Shigeki Taniguchi, MD PhD, Masanori Matsumoto, MD PhD, Kazuo Tsubaki, MD PhD, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 2857.

https://doi.org/10.1182/blood.V124.21.2857.2857

Published: 2014

Journal Articles

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Kazuyoshi Ishii, MD MPH, PhD, Shosaku Nomura, MD PhD, Tomoki Ito, MD PhD, Yuta Katayama, MD PhD, Taiichi Kyo, MD, Shuichi Ota, MD PhD, Masanori Seki, MD PhD, Shigeru Chiba, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD, Takayuki Ikezoe, MD PhD, Hideo Yagi, MD PhD, Yoji Ishida, MD, PhD, Naohito Fujishima, MD PhD, Kenichi Sawada, MDPhD

Blood (2014) 124 (21): 5089.

https://doi.org/10.1182/blood.V124.21.5089.5089

Published: 2014

Journal Articles

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Yumi Yoshii, MD, Masanori Matsumoto, MD PhD, Kurumatani Norio, MD PhD, Ayami Isonishi, BS, Masahito Uemura, MD PhD, Yuji Hori, PhD, Masaki Hayakawa, MD, Hideo Yagi, MD PhD, Charles L Bennett, MD PhD MPP, Yoshihiro Fujimura, MD PhD

Blood (2014) 124 (21): 4209.

https://doi.org/10.1182/blood.V124.21.4209.4209

Published: 2014

Journal Articles

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Kazuyoshi Ishii, MD, MPH, PhD, Shosaku Nomura, MD, PhD, Tomoki Ito, MD, PhD, Yuta Katayama, MD, PhD, Taiichi Kyo, MD, Shuichi Ota, MD, PhD, Masanori Seki, MD, PhD, Shigeru Chiba, MD, PhD, Yoshinobu Maeda, M.D., Ph.D., Mitsune Tanimoto, MD, PhD, Takayuki Ikezoe, MD. PhD, Hideo Yagi, MD, PhD, Yoji Ishida, M.D., Ph.D., Naohito Fujishima, MD, PhD, Kenichi Sawada, MD, PhD

Blood (2013) 122 (21): 5454.

https://doi.org/10.1182/blood.V122.21.5454.5454

Published: 2013

Journal Articles

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tsubaki, MD, PhD

Blood (2013) 122 (21): 1963.

https://doi.org/10.1182/blood.V122.21.1963.1963

Published: 2013

Journal Articles

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Yoshihiro Fujimura, MD, PhD, Yumi Yoshii, MD, Masanori Matsumoto, MD, PhD, Ayami Isonishi, BS, Masaki Hayakawa, MD, Yoko Yoshida, MS, Hideo Yagi, MD, PhD, Koichi Kokame, PhD, Toshiyuki Miyata, PhD

Blood (2013) 122 (21): 3545.

https://doi.org/10.1182/blood.V122.21.3545.3545

Published: 2013

Journal Articles

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

Yoko Yoshida, MS, Xinping Fan, MD, Yoshifumi Ohyama, PhD, Tetsuro Kokubo, PhD, Masanori Matsumoto, MD, PhD, Hideo Yagi, MD, PhD, Hiroko Shirotani-Ikejima, PhD, Toshiyuki Miyata, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 2318.

https://doi.org/10.1182/blood.V122.21.2318.2318

Published: 2013

Journal Articles

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Masaki Hayakawa, MD, Masanori Matsumoto, MD, PhD, Yumi Yoshii, MD, Hideo Yagi, MD, PhD, Hiroshi Kimura, MD, PhD, Yoshihiro Fujimura, MD, PhD

Blood (2013) 122 (21): 3625.

https://doi.org/10.1182/blood.V122.21.3625.3625

Published: 2013

NARROW

Efficacy and Safety of Polatuzumab-Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) in the Real-World Setting: A Single Institute Retrospective Analysis

Immediate Therapeutic Intervention for Acute Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura with Positive Chest Findings at Initial Presentation

Persistent ADAMTS13 Inhibitor May Lead to Delayed ADAMTS13 Recovery in Japanese Patients with Caplacizumab-Treated Immune-Mediated Thrombotic Thrombocytopenic Purpura

Next-Generation Sequencing of HLA Loci Identifies Predisposing and Protective Factors for Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Japanese Population

Inhibitory Effect of a Novel DNA Aptamer with Artificial Nucleic Bases for Von Willebrand Factor A1 Domain on Platelet Thrombosis Formation

A New Prognostic Index for Waldenström Macroglobulinemia Based on a Multicenter Retrospective Study of the Japanese Society of Myeloma

Severe Reduction of Free ADAMTS13, Unbound to Von Willebrand Factor, in Plasma Milieu Is a Unique Feature of HELLP Syndrome

Quantitative ELISA Using N10 Antibody, Targeting on VWF-Y1605 Residue, Indicates That N-Linked Blood Group Type A Carbohydrate on VWF Molecule Functions Against ADAMTS13 Cleavage

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation: A Multi-Center Study in Japan

A Comparison of Minimal Residual Disease Detection Among ASO-PCR, Dd-PCR and Deep-Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation

Prognostic Value of Sequencing-Based Minimal Residual Disease Detection in Multiple Myeloma

Decreased Platelet Thrombus Size, Due to a Heightened Proteolysis of VWF By ADAMTS13, Is Quickly Restored after Valve Replacement in Aortic Stenosis Patients

Recombinant Thrombomodulin for the Treatment of Transplantation-Associated Coagulopathy after Allogeneic Hematopoietic Stem Cell Transplantation

Introduction of a Quick Assay for ADAMTS13 Activity Improved a Survival of Acquired TTP Patients Who Received Platelet Transfusions

Recombinant Thrombomodurin For The Treatment Of Transplantation-Associated Coagulopathy After Allogeneic Stem Cell Transplantation

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis

Atypical Hemolytic Uremic Syndrome In Japan Characterized By The Inhibitory Antibody-Based Hemolytic Assay and The Gene Analysis

HSCT-Associated Hepatic VOD Is Initiated With Preceding Appearance Of Unusually Large Von Willebrand Factor Multimers In Patient Plasmas

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only